• 1
    Torbicki A, Perrier A, Konstantinides S, et al.Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). European Heart Journal2008; 29: 2276315.
  • 2
    Joynt GM, Kew J, Gomersall CD, Leung VY, Liu EK. Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest2000; 117: 17883.
  • 3
    Schwartz T, Hingorani A, Ascher E, et al.Pulmonary embolism without deep venous thrombosis. Annals of Vascular Surgery2012; 26: 9736.
  • 4
    Nchimi A, Ghaye B, Noukoua CT, Dondelinger RF. Incidence and distribution of lower extremity deep venous thrombosis at indirect computed tomography venography in patients suspected of pulmonary embolism. Thrombosis and Haemostasis2007; 97: 56672.
  • 5
    van Langevelde K, Sramek A, Vincken PWJ, van Rooden J-K, Rosendaal FR, Cannegieter SC. Finding the origin of pulmonary embolism with a total-body magnetic resonance direct thrombus imaging technique. Haematologica 2012 Jul 16. [Epub ahead of print].
  • 6
    Kasper W, Geibel A, Tiede N, Just H. Patent foramen ovale in patients with haemodynamically significant pulmonary embolism. Lancet1992; 340: 5614.
  • 7
    Nordstrom M, Lindblad B. Autopsy-verified venous thromboembolism within a defined urban population--the city of Malmo, Sweden. Acta Pathologica, Microbiologica et Immunologica Scandinavica1998; 106: 37884.
  • 8
    Cohen AT, Agnelli G, Anderson FA, et al.Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortalityThrombosis and Haemostasis. 2007; 98: 75664.
  • 9
    Mahan CE, Borrego ME, Woersching AL, et al.Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thrombosis and Haemostasis2012; 108: 291302.
  • 10
    Kumar G, Sakhuja A, Taneja A, et al.Pulmonary embolism in patients with CKD and ESRD. Clinical Journal of the American Society of Nephrology2012; 7: 158490.
  • 11
    Remy-Jardin M, Pistolesi M, Goodman LR, et al.Management of suspected acute pulmonary embolism in the era of CT angiography: a statement from the Fleischner Society. Radiology2007; 245: 31529.
  • 12
    Carrier M, Righini M, Wells PS, et al.Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. Journal of Thrombosis and Haemostasis2010; 8: 171622.
  • 13
    Ong CW, Malipatil V, Lavercombe M, et al.Implementation of a clinical prediction tool for pulmonary embolism diagnosis in a tertiary teaching hospital reduces the number of CT pulmonary angiograms performed. Internal Medicine Journal 2012, Aug 22. [Epub ahead of print].
  • 14
    Rohacek M, Buatsi J, Szucs-Farkas Z, et al.Ordering CT pulmonary angiography to exclude pulmonary embolism: defense versus evidence in the emergency room. Intensive Care Medicine2012; 38: 134551.
  • 15
    Mettler FA, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog1. Radiology2008; 248: 25463.
  • 16
    Berrington de Gonzalez A, Mahesh M, Kim K-P, et al.Projected cancer risks from computed tomographic scans performed in the United States in 2007. Archives of Internal Medicine2009; 169: 20717.
  • 17
    Patel R, Cook DJ, Meade MO, et al.Burden of illness in venous thromboembolism in critical care: a multicenter observational study. Journal of Critical Care2005; 20: 3417.
  • 18
    Timsit JF, Farkas JC, Boyer JM, et al.Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest1998; 114: 20713.
  • 19
    Bonizzoli M, Batacchi S, Cianchi G, et al.Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients. Intensive Care Medicine2011; 37: 2849.
  • 20
    Hingorani A, Ascher E, Markevich N, et al.Risk factors for mortality in patients with upper extremity and internal jugular deep venous thrombosis. Journal of Vascular Surgery2005; 41: 4768.
  • 21
    Ascher E, Salles-Cunha S, Hingorani A. Morbidity and mortality associated with internal jugular vein thromboses. Vascular and Endovascular Surgery2005; 39: 3359.
  • 22
    Levy MM, Albuquerque F, Pfeifer JD. Low incidence of pulmonary embolism associated with upper-extremity deep venous thrombosis. Annals of Vascular Surgery2012; 26: 964–72.
  • 23
    Kearon C, Akl EA, Comerota AJ, et al.Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest2012; 141: e419S94S.
  • 24
    Geibel A, Zehender M, Kasper W, Olschewski M, Klima C, Konstantinides SV. Prognostic value of the ECG on admission in patients with acute major pulmonary embolism. European Respiratory Journal2005; 25: 8438.
  • 25
    Rodger M, Makropoulos D, Turek M, et al. Diagnostic value of the electrocardiogram in suspected pulmonary embolism. American Journal of Cardiology2000; 86: 8079, A10.
  • 26
    Lobo JL, Zorrilla V, Aizpuru F, et al.D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE Registry. Journal of Thrombosis and Haemostasis2009; 7: 1795801.
  • 27
    Ferrari E, Moceri P, Crouzet C, Doyen D, Cerboni P. Timing of troponin I measurement in pulmonary embolism. Heart2012; 98: 7325.
  • 28
    Kurzyna M, Torbicki A, Pruszczyk P, et al.Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism. American Journal of Cardiology2002; 90: 50711.
  • 29
    Casazza F, Bongarzoni A, Capozi A, Agostoni O. Regional right ventricular dysfunction in acute pulmonary embolism and right ventricular infarction. European Journal of Echocardiography2005; 6: 114.
  • 30
    Hsiao SH, Chang SM, Lee CY, Yang SH, Lin SK, Chiou KR. Usefulness of tissue Doppler parameters for identifying pulmonary embolism in patients with signs of pulmonary hypertension. American Journal of Cardiology2006; 98: 68590.
  • 31
    Henzler T, Schoenberg SO, Schoepf UJ, Fink C. Diagnosing acute pulmonary embolism: systematic review of evidence base and cost-effectiveness of imaging tests. Journal of Thoracic Imaging2012; 27: 30414.
  • 32
    Bauer RW, Frellesen C, Renker M, et al.Dual energy CT pulmonary blood volume assessment in acute pulmonary embolism - correlation with D-dimer level, right heart strain and clinical outcome. European Radiology2011; 21: 191421.
  • 33
    Aviram G, Sirota-Cohen C, Steinvil A, et al.Automated volumetric analysis of four cardiac chambers in pulmonary embolism. A novel technology for fast risk stratification. Thrombosis and Haemostasis2012; 108: 38493.
  • 34
    Hirai LK, Takahashi JM, Yoon HC. A prospective evaluation of a quantitative D-dimer assay in the evaluation of acute pulmonary embolism. Journal of Vascular and Interventional Radiology2007; 18: 9704.
  • 35
    Cecconi M, Johnston E, Rhodes A. What role does the right side of the heart play in circulation?Critical Care2006; 10 (Suppl. 3): S5.
  • 36
    Price LC, Wort SJ, Finney SJ, Marino PS, Brett SJ. Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Critical Care2010; 14: R169.
  • 37
    Maybauer M, Maybauer D. Vasopressin analogues and V1a receptor agonists in septic shock. Inflammation Research2011; 60: 4257.
  • 38
    Barra S, Paiva L, Providencia R. Challenging pulmonary embolism - a new generation of oral anticoagulants. Journal of Thoracic Disease2012; 4: 2446.
  • 39
    Stein PD, Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. American Journal of Medicine2012; 125: 46570.
  • 40
    Bulpa P, Carbutti G, Osselaer J-C, Lawson G, Dive A, Evrard P. Low-dose urokinase in massive pulmonary embolism when standard thrombolysis is contraindicated. Chest2009; 136: 11413.
  • 41
    Riera-Mestre A, Jimenez D, Muriel A, et al.Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism. Journal of Thrombosis and Haemostasis2012; 10: 7519.
  • 42
    Ibrahim SA, Stone RA, Obrosky DS, Geng M, Fine MJ, Aujesky D. Thrombolytic therapy and mortality in patients with acute pulmonary embolism. Archives of Internal Medicine2008; 168: 218390.
  • 43
    Dong BR, Hao Q, Yue J, Wu T, Liu GJ. Thrombolytic therapy for pulmonary embolism. Cochrane Database of Systematic Reviews2009; 8: CD004437.
  • 44
    Imberti D, Ageno W, Manfredini R, et al.. Interventional treatment of venous thromboembolism: a review. Thrombosis Research2012; 129: 41825.
  • 45
    Stein PD, Matta F, Keyes DC, Willyerd GL. Impact of vena cava filters on in-hospital case fatality rate from pulmonary embolism. American Journal of Medicine2012; 125: 47884.
  • 46
    Meneveau N, Seronde MF, Blonde MC, et al.Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest2006; 129: 104350.
  • 47
    Leacche M, Unic D, Goldhaber SZ, et al.Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. Journal of Thoracic and Cardiovascular Surgery2005; 129: 101823.
  • 48
    Aklog L, Williams CS, Byrne JG, Goldhaber SZ. Acute pulmonary embolectomy: a contemporary approach. Circulation2002; 105: 14169.
  • 49
    Stein PD, Matta F. Case fatality rate with pulmonary embolectomy for acute pulmonary embolism. The American Journal of Medicine2012; 125: 4717.
  • 50
    Hall D. Perioperative pulmonary embolism: detection, treatment, and outcomes. American Journal of Therapeutics 2012 Jun 22. [Epub ahead of print].
  • 51
    Lowhagen O. Diagnosis of asthma - a new approach. Allergy2012; 67: 7137.
  • 52
    A plea to abandon asthma as a disease concept. Lancet2006; 368: 705.
  • 53
    Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet2006; 368: 80413.
  • 54
    Hashimoto S, Bel EH. Current treatment of severe asthma. Clinical and Experimental Allergy2012; 42: 693705.
  • 55
    Gibeon D, Chung KF. The investigation of severe asthma to define phenotypes. Clinical and Experimental Allergy2012; 42: 67892.
  • 56
    Saritas Yuksel E, Vaezi MF. Extraesophageal manifestations of gastroesophageal reflux disease: cough, asthma, laryngitis, chest pain. Swiss Medical Weekly2012; 142: w13544.
  • 57
    de Groot EP. Breathing abnormalities in children with breathlessness. Paediatric Respiratory Reviews2011; 12: 837.
  • 58
    Lemanske RF Jr, Busse WW. Asthma: clinical expression and molecular mechanisms. Journal of Allergy and Clinical Immunology2010; 125: S95102.
  • 59
    Burgel PR, Paillasseur JL, Caillaud D, et al.Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. European Respiratory Journal2010; 36: 5319.
  • 60
    Miravitlles M, Calle M, Soler-Cataluna JJ. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Archivos de Bronconeumologia2012; 48: 8698.
  • 61
    Coxson HO, Mayo J, Lam S, Santyr G, Parraga G, Sin DD. New and current clinical imaging techniques to study chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine2009; 180: 58897.
  • 62
    Soler-Cataluna JJ, Cosio B, Izquierdo JL, et al.Consensus document on the overlap phenotype COPD-asthma in COPD. Archivos de Bronconeumologia2012; 48: 3317.
  • 63
    Mandal S, Hart N. Respiratory complications of obesity. Clinical Medicine2012; 12: 758.
  • 64
    Barranco P, Delgado J, Gallego LT, et al.Asthma, obesity and diet. Nutricion Hospitalaria2012; 27: 13845.
  • 65
    Oddo M, Feihl F, Schaller MD, Perret C. Management of mechanical ventilation in acute severe asthma: practical aspects. Intensive Care Medicine2006; 32: 50110.
  • 66
    British Guideline on the Management of Asthma. London: British Thoracic Society. Revised June 2009.
  • 67
    Johnston NW, Sears MR. Asthma exacerbations. 1: epidemiology. Thorax2006; 61: 7228.
  • 68
    Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. Journal of Allergy and Clinical Immunology2011; 128: 116574.
  • 69
    Yonas MA, Lange NE, Celedon JC. Psychosocial stress and asthma morbidity. Current Opinion in Allergy and Clinical Immunology2012; 12: 20210.
  • 70
    Peters JI, Stupka JE, Singh H, et al.Status asthmaticus in the medical intensive care unit: a 30-year experience. Respiratory Medicine2012; 106: 3448.
  • 71
    Gupta D, Keogh B, Chung KF, et al.Characteristics and outcome for admissions to adult, general critical care units with acute severe asthma: a secondary analysis of the ICNARC Case Mix Programme Database. Critical Care2004; 8: R11221.
  • 72
    Stow PJ, Pilcher D, Wilson J, et al.Improved outcomes from acute severe asthma in Australian intensive care units (1996–2003). Thorax2007; 62: 8427.
  • 73
    Tepper RS, Wise RS, Covar R, et al.Asthma outcomes: pulmonary physiology. Journal of Allergy and Clinical Immunology2012; 129: S6587.
  • 74
    Myers TR. Guidelines for asthma management: a review and comparison of 5 current guidelines. Respiratory Care2008; 53: 75167.
  • 75
    Moloney E, O’Sullivan S, Hogan T, Poulter LW, Burke CM. Airway dehydration: a therapeutic target in asthma?Chest2002; 121: 180611.
  • 76
    Bolger C, Tufvesson E, Anderson SD, et al.Effect of inspired air conditions on exercise-induced bronchoconstriction and urinary CC16 levels in athletes. Journal of Applied Physiology2011; 111: 105965.
  • 77
    Chien JW, Ciufo R, Novak R, et al.Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest2000; 117: 72833.
  • 78
    Rodrigo GJ, Rodriquez Verde M, Peregalli V, Rodrigo C. Effects of short-term 28% and 100% oxygen on PaCO2 and peak expiratory flow rate in acute asthma: a randomized trial. Chest2003; 124: 13127.
  • 79
    Drug monographs - Salbutamol. In: Sweetman SCe, ed. Martindale: The Complete Drug Reference [online]. London: Pharmaceutical Press, 2011.
  • 80
    Rodrigo C, Rodrigo G. Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma. Chest1998; 113: 5938.
  • 81
    Emerman CL, Cydulka RK, McFadden ER. Comparison of 2.5 vs 7.5 mg of inhaled albuterol in the treatment of acute asthma. Chest1999; 115: 926.
  • 82
    Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database of Systematic Reviews2003; 4: CD001115.
  • 83
    Rodrigo GJ, Rodrigo C. Continuous vs intermittent beta-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis. Chest2002; 122: 1605.
  • 84
    Reay CA, Bousfield DR, Colechin ES, Menes JA, Sims AJ. Buyers’ Guide: Nebulizers. London: NHS Purchasing and Supply Agency Centre for Evidence-based Purchasing, 2009.
  • 85
    Ruickbie S, Hall A, Ball J. Therapeutic aerosols in mechanically ventilated patients. In: Vincent J-L, ed. In Annual Update in Intensive Care and Emergency Medicine. Berlin: Springer-Verlag, 2011: 197206.
  • 86
    Goral V, Jin Y, Sun H, Ferrie AM, Wu Q, Fang Y. Agonist-directed desensitization of the beta2-adrenergic receptor. PLoS ONE2011; 6: e19282.
  • 87
    Tobin AE, Pellizzer AM, Santamaria JD. Mechanisms by which systemic salbutamol increases ventilation. Respirology2006; 11: 1827.
  • 88
    Ameredes BT, Calhoun WJ. Rebuttal by Drs Ameredes and Calhoun. American Journal of Respiratory and Critical Care Medicine2006; 174: 9724.
  • 89
    Broadley KJ. Beta-adrenoceptor responses of the airways: for better or worse?European Journal of Pharmacology2006; 533: 1527.
  • 90
    Handley D. The asthma-like pharmacology and toxicology of (S)-isomers of beta agonists. Journal of Allergy and Clinical Immunology1999; 104: S6976.
  • 91
    Ameredes BT, Calhoun WJ. (R)-albuterol for asthma: pro [a.k.a. (S)-albuterol for asthma: con]. American Journal of Respiratory and Critical Care Medicine2006;174:9659; discussion 72-4.
  • 92
    Travers AH, Rowe BH, Barker S, Jones A, Camargo CA Jr. The effectiveness of IV beta-agonists in treating patients with acute asthma in the emergency department: a meta-analysis. Chest2002; 122: 12007.
  • 93
    Tobin A. Intravenous salbutamol: too much of a good thing?Critical Care and Resuscitation2005; 7: 11927.
  • 94
    Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax2005; 60: 7406.
  • 95
    Kistemaker LE, Oenema TA, Meurs H, Gosens R. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD. Life Sciences 2012 Mar 3. [Epub ahead of print]
  • 96
    Meurs H, Dekkers BG, Maarsingh H, Halayko AJ, Zaagsma J, Gosens R. Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target. Pulmonary Pharmacology and Therapeutics 2012 Jul 25. [Epub ahead of print]
  • 97
    Moulton BC, Fryer AD. Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD. British Journal of Pharmacology2011; 163: 4452.
  • 98
    Hancox RJ. Interactions between corticosteroids and beta2-agonists. Clinical Reviews in Allergy and Immunology2006; 31: 23146.
  • 99
    Rowe BH, Vethanayagam D. The role of inhaled corticosteroids in the management of acute asthma. European Respiratory Journal2007; 30: 10357.
  • 100
    Rodrigo GJ. Inhaled corticosteroids as rescue medication in acute severe asthma. Expert Review of Clinical Immunology2008; 4: 7239.
  • 101
    Horvath G, Wanner A. Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma. European Respiratory Journal2006; 27: 17287.
  • 102
    Song WJ, Chang YS. Magnesium sulfate for acute asthma in adults: a systematic literature review. Asia Pacific Allergy2012; 2: 7685.
  • 103
    Dominguez LJ, Barbagallo M, Di Lorenzo G, et al.Bronchial reactivity and intracellular magnesium: a possible mechanism for the bronchodilating effects of magnesium in asthma. Clinical Science (London–England)1998; 95: 13742.
  • 104
    Silverman RA, Osborn H, Runge J, et al.IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial. Chest2002; 122: 48997.
  • 105
    Wiebe K, Rowe BH. Nebulized racemic epinephrine used in the treatment of severe asthmatic exacerbation: a case report and literature review. Canadian Journal of Emergency Medicine2007; 9: 3048.
  • 106
    Putland M, Kerr D, Kelly AM. Adverse events associated with the use of intravenous epinephrine in emergency department patients presenting with severe asthma. Annals of Emergency Medicine2006; 47: 55963.
  • 107
    Camargo CA Jr, Gurner DM, Smithline HA, et al.A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. Journal of Allergy and Clinical Immunology2010; 125: 37480.
  • 108
    Ramsay CF, Pearson D, Mildenhall S, Wilson AM. Oral montelukast in acute asthma exacerbations: a randomised, double-blind, placebo-controlled trial. Thorax2011; 66: 711.
  • 109
    Adamzik M, Groeben H, Farahani R, Lehmann N, Peters J. Intravenous lidocaine after tracheal intubation mitigates bronchoconstriction in patients with asthma. Anesthesia & Analgesia2007; 104: 16872.
  • 110
    Serra MF, Anjos-Valotta EA, Olsen PC, et al.Nebulized lidocaine prevents airway inflammation, peribronchial fibrosis, and mucus production in a murine model of asthma. Anesthesiology2012; 117: 58091.
  • 111
    McCarthy GC, Megalla SA, Habib AS. Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials. Drugs2010; 70: 114963.
  • 112
    Wright JL, Durieux ME, Groves DS. A brief review of innovative uses for local anesthetics. Current Opinion in Anesthesiology2008; 21: 6516.
  • 113
    Abuan T, Yeager M, Montgomery AB. Inhaled lidocaine for the treatment of asthma: lack of efficacy in two double-blind, randomized, placebo-controlled clinical studies. Journal of Aerosol Medicine and Pulmonary Drug Delivery2010; 23: 3818.
  • 114
    Hunt LW, Frigas E, Butterfield JH, et al.Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study. Journal of Allergy and Clinical Immunology2004; 113: 8539.
  • 115
    Parameswaran K, Belda J, Rowe Brian H. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database of Systematic Reviews. 2000; 4: CD002742
  • 116
    Yen ZS, Chen SC. Best evidence topic report nebulised furosemide in acute adult asthma. Emergency Medicine Journal2005; 22: 6545.
  • 117
    Creagh-Brown BC, Ball J. An under-recognized complication of treatment of acute severe asthma. American Journal of Emergency Medicine2008; 26: 514.e1-e3.
  • 118
    Ball J. Helium-oxygen gas mixtures. In: Waldmann C, Soni N, Rhodes A, eds. In Oxford Desk Reference: Critical Care. Oxford: Oxford University Press, 2008: 1623.
  • 119
    Ram FS, Wellington S, Rowe B, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database of Systematic Reviews2005; 3: CD004360.
  • 120
    Stather DR, Stewart TE. Clinical review: mechanical ventilation in severe asthma. Critical Care2005; 9: 5817.
  • 121
    Abdelsalam M, Cheifetz IM. Goal-directed therapy for severely hypoxic patients with acute respiratory distress syndrome: permissive hypoxemia. Respiratory Care2010; 55: 148390.
  • 122
    Ijland MM, Heunks LM, van der Hoeven JG. Bench-to-bedside review: hypercapnic acidosis in lung injury--from ‘permissive’ to ‘therapeutic’. Critical Care2010; 14: 237.
  • 123
    Mikkelsen ME, Woo YJ, Sager JS, Fuchs BD, Christie JD. Outcomes using extracorporeal life support for adult respiratory failure due to status asthmaticus. American Society for Artificial Internal Organs Journal2009; 55: 4752.